Monthly Archives: May 2015

Continuing Fallout from the Decision to Overturn Myriad’s Patents

I follow the genetic testing field and have watched the field’s developments since the Myriad decision on patentability of genetic sequences with great interest. One very interesting and very important question is whether the ability to patent naturally occurring genetic … Continue reading






Posted in DTC Genetic Testing, genomics, Oncology, personalized medicine | Comments Off on Continuing Fallout from the Decision to Overturn Myriad’s Patents